HDHD2, or Haloacid Dehalogenase-Like Hydrolase Domain Containing 2, is an enzyme encoded by the HDHD2 gene in humans. It belongs to the haloacid dehalogenase (HAD) superfamily, which comprises a large group of hydrolases. These enzymes are characterized by their ability to catalyze the hydrolysis of a wide range of substrates, including phosphates, sulfates, and carboxylic acid esters.HDHD2 specifically exhibits phosphatase activity, functioning in the dephosphorylation of various substrates within the cell. This enzymatic action is crucial for regulating the phosphorylation status of proteins and other molecules, which is a key mechanism in controlling cellular processes such as signal transduction, metabolism, and cell growth.
The precise biological role of HDHD2 is not fully elucidated, but its phosphatase activity suggests its involvement in important cellular pathways. Phosphorylation and dephosphorylation are essential for the modulation of enzyme activities, the activation/inactivation of signaling pathways, and the regulation of cell cycle progression. Therefore, HDHD2 likely plays a role in these processes through its enzymatic function.Alterations in the expression or function of HDHD2 could have significant implications for cellular regulation and homeostasis. Abnormal HDHD2 activity may be linked to various pathologies, including metabolic disorders, signal transduction abnormalities, and potentially cancer, given the critical role of phosphatases in cell growth and proliferation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which could indirectly influence HDHD2 by modulating cellular signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterase, leading to increased cAMP and cGMP levels in cells, potentially impacting HDHD2 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a selective phosphodiesterase 4 inhibitor, increases cAMP levels, potentially affecting signaling pathways relevant to HDHD2. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, a known phosphodiesterase inhibitor, can increase cAMP levels, possibly influencing HDHD2 activity indirectly. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, with its broad biological activity, can modulate various cellular pathways, potentially intersecting with HDHD2's function. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline, another phosphodiesterase inhibitor, increases cAMP levels, potentially affecting pathways involving HDHD2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a major component of green tea, has a wide range of biological effects, including modulation of signaling pathways that might interact with HDHD2. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone, a phosphodiesterase 3 inhibitor, increases cAMP levels, which could have implications for HDHD2 activity. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Pentoxifylline, a phosphodiesterase inhibitor, elevates cAMP levels and could indirectly affect HDHD2's role in cellular signaling. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine, a phosphodiesterase 1 inhibitor, increases cAMP and cGMP levels, potentially impacting HDHD2 activity. | ||||||